BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

BCL-6, a transcriptional repressor frequently translocated in lymphomas, regulates germinal center B cell differentiation and inflammation. DNA microarray screening identified genes repressed by BCL-6, including many lymphocyte activation genes, suggesting that BCL-6 modulates B cell receptor signals. BCL-6 repression of two chemokine genes, MIP-1alpha and IP-10, may also attenuate inflammatory responses. Blimp-1, another BCL-6 target, is important for plasmacytic differentiation. Since BCL-6 expression is silenced in plasma cells, repression of blimp-1 by BCL-6 may control plasmacytic differentiation. Indeed, inhibition of BCL-6 function initiated changes indicative of plasmacytic differentiation, including decreased expression of c-Myc and increased expression of the cell cycle inhibitor p27kip1. These data suggest that malignant transformation by BCL-6 involves inhibition of differentiation and enhanced proliferation.

[1]  Sanjay Gupta,et al.  Lineage-Specific Modulation of Interleukin 4 Signaling by Interferon Regulatory Factor 4 , 1999, The Journal of experimental medicine.

[2]  D. Goeddel,et al.  Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes , 1993, The Journal of experimental medicine.

[3]  R. Strieter,et al.  Macrophage inflammatory protein‐1α influences eosinophil recruitment in antigen‐specific airway inflammation , 1995 .

[4]  Mark M. Davis,et al.  Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells , 1994, Cell.

[5]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  F. Sánchez‐Madrid,et al.  Transcriptional Regulation of the Gene Encoding the Human C-type Lectin Leukocyte Receptor AIM/CD69 and Functional Characterization of Its Tumor Necrosis Factor-α-responsive Elements (*) , 1995, The Journal of Biological Chemistry.

[7]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  L. Staudt,et al.  Control of inflammation, cytokine expression, and germinal center formation by BCL-6. , 1997, Science.

[9]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[10]  N. Hay,et al.  c-Myc induces the expression and activity of ornithine decarboxylase. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[11]  J. Monroe,et al.  Immature stage B cells enter but do not progress beyond the early G1 phase of the cell cycle in response to antigen receptor signaling. , 1996, Journal of immunology.

[12]  M. Parker,et al.  Interaction of proteins with transcriptionally active estrogen receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Staudt,et al.  Transcriptional repression by the proto-oncogene BCL-6. , 1996, Oncogene.

[14]  P. Pandolfi,et al.  Transcriptional Repression of Stat6-Dependent Interleukin-4-Induced Genes by BCL-6: Specific Regulation of Iɛ Transcription and Immunoglobulin E Switching , 1999, Molecular and Cellular Biology.

[15]  J. D. Engel,et al.  Regulation and function of transcription factor GATA-1 during red blood cell differentiation. , 1996, Development.

[16]  Juan F. García,et al.  Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. , 1999 .

[17]  N. Zeleznik-Le,et al.  BCL6 encodes a sequence‐specific DNA‐binding Protein , 1995, Genes, chromosomes & cancer.

[18]  L. Staudt,et al.  BCL-6 expression during B-cell activation. , 1996, Blood.

[19]  J. Gordon,et al.  Co-ligation of surface IgM and CD40 on naive B lymphocytes generates a blast population with an ambiguous extrafollicular/germinal centre cell phenotype. , 1996, International immunology.

[20]  P. Pandolfi,et al.  The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation , 1997, Nature Genetics.

[21]  E. Campo,et al.  Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. , 1998, The American journal of pathology.

[22]  I. Berberich,et al.  Reversal of Blimp‐1‐mediated apoptosis by A1, a member of the Bcl‐2 family , 1999, European journal of immunology.

[23]  Mark M. Davis,et al.  Differential Effect of B Lymphocyte–induced Maturation Protein (Blimp-1) Expression on Cell Fate during B Cell Development , 1998, The Journal of experimental medicine.

[24]  D. M. Weir,et al.  Handbook of experimental immunology , 1967 .

[25]  P G Soro,et al.  Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells. , 1999, Journal of immunology.

[26]  M. Hatano,et al.  Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation , 1997, The Journal of experimental medicine.

[27]  C. Murre,et al.  E2A activity is induced during B‐cell activation to promote immunoglobulin class switch recombination , 1999, The EMBO journal.

[28]  E. Kieff,et al.  Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes , 1993, Journal of virology.

[29]  A. Foussat,et al.  Antigen Receptor Engagement Selectively Induces Macrophage Inflammatory Protein-1α (MIP-1α) and MIP-1β Chemokine Production in Human B Cells , 1999, The Journal of Immunology.

[30]  Y. H. Kim,et al.  Characterization of the murine cyclin D2 gene: exon/intron organization and promoter activity. , 1997, Molecules and cells.

[31]  K. Offit,et al.  BCL-6 protein is expressed in germinal-center B cells. , 1995, Blood.

[32]  R. Dalla‐Favera,et al.  Molecular pathogenesis of B cell malignancy: the role of BCL-6. , 1999, Current topics in microbiology and immunology.

[33]  H Stein,et al.  A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. , 2000, Blood.

[34]  Ash A. Alizadeh,et al.  The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. , 1999, Cold Spring Harbor symposia on quantitative biology.

[35]  Wei Wei Wu,et al.  Induction of cell cycle regulatory proteins in anti-immunoglobulin- stimulated mature B lymphocytes , 1996, The Journal of experimental medicine.

[36]  L. Staudt,et al.  Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. , 1999, International reviews of immunology.

[37]  A. Cerami,et al.  Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. , 1993, Journal of immunology.

[38]  J. Farber.  Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[39]  James M. Roberts,et al.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.

[40]  D. Leprince,et al.  Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene , 1999, Oncogene.

[41]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[42]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[43]  E. Puré,et al.  High levels of CD44 expression distinguish virgin from antigen-primed B cells , 1991, The Journal of experimental medicine.

[44]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[45]  K. Calame,et al.  Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. , 1997, Science.

[46]  Y. Hosokawa,et al.  Cloning and functional analysis of rat cyclin D2 promoter: multiple prolactin‐responsive elements , 1997, Biochemistry and molecular biology international.

[47]  J. Sheridan,et al.  Requirement of MIP-1 alpha for an inflammatory response to viral infection. , 1995, Science.

[48]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[49]  S. Mori,et al.  BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. , 1995, Blood.

[50]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.